These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry. Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267 [TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813 [TBL] [Abstract][Full Text] [Related]
6. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage. Reisinger D; Gojo J; Kasprian G; Haberler C; Peyrl A; Azizi AA; Mayr L; Chocholous M; Kool M; Czech T; Slavc I Neurosurgery; 2020 Apr; 86(4):478-484. PubMed ID: 31065705 [TBL] [Abstract][Full Text] [Related]
7. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700 [TBL] [Abstract][Full Text] [Related]
8. MRI Characteristics of Primary Tumors and Metastatic Lesions in Molecular Subgroups of Pediatric Medulloblastoma: A Single-Center Study. Mata-Mbemba D; Zapotocky M; Laughlin S; Taylor MD; Ramaswamy V; Raybaud C AJNR Am J Neuroradiol; 2018 May; 39(5):949-955. PubMed ID: 29545246 [TBL] [Abstract][Full Text] [Related]
9. MRI surrogates for molecular subgroups of medulloblastoma. Perreault S; Ramaswamy V; Achrol AS; Chao K; Liu TT; Shih D; Remke M; Schubert S; Bouffet E; Fisher PG; Partap S; Vogel H; Taylor MD; Cho YJ; Yeom KW AJNR Am J Neuroradiol; 2014 Jul; 35(7):1263-9. PubMed ID: 24831600 [TBL] [Abstract][Full Text] [Related]
10. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706 [TBL] [Abstract][Full Text] [Related]
11. Implications of tumor location on subtypes of medulloblastoma. Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma. Chang FC; Wong TT; Wu KS; Lu CF; Weng TW; Liang ML; Wu CC; Guo WY; Chen CY; Hsieh KL PLoS One; 2021; 16(7):e0255500. PubMed ID: 34324588 [TBL] [Abstract][Full Text] [Related]
13. Are the Radiological and Molecular Features of Pediatric Medulloblastomas Valuable Prognostic Indicators? A 10-Year Retrospective Review in the Middle East. Alhaj AK; Burhamah T; Mohammad F; Almutawa M; Dashti F; Almurshed M; Behzad S; Snuderl M; Hasan A World Neurosurg; 2024 Jul; 187():e156-e165. PubMed ID: 38636638 [TBL] [Abstract][Full Text] [Related]
14. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823 [TBL] [Abstract][Full Text] [Related]
15. Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Clifford SC; Lusher ME; Lindsey JC; Langdon JA; Gilbertson RJ; Straughton D; Ellison DW Cell Cycle; 2006 Nov; 5(22):2666-70. PubMed ID: 17172831 [TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma in the age of molecular subgroups: a review. Juraschka K; Taylor MD J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]